NeuralThera (NURL:CSE) closed at $0.010 on October 23, 2026, down 33.33% on the day. It is trading at its 52-week low of $0.010. Over the past year, it lost 50.0%. NeuralThera is part of the Diversified Industries sector.
In 252 trading sessions since October 23, 2025, NURL closed higher on 30 days (12%). Its best day was October 24, 2025 (+100.00%) and its worst was November 26, 2025 (-33.33%). The stock moved 10% or more in a single session 62 times. It opened at least 5% above the previous day's high 26 times.
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
Find more stocks like NURL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.